glp-1 news 2025 november New oral drug delivers up to 12% weight loss in 36 weeks The GLP-1 Access Gap: Mapping

Description

CMS did not explain the rationale behind their approach.) CMS specified that if the 80% threshold was not met, CMS would not move forward with the BALANCE Model in Medicare in 2027, and that appears to be what occurred, as CMSs April 21, 2026 announcement suggests

The Rewards Mastercard also works

Combining a slow-moving stomach with an irritant like alcohol is a recipe for heartburn, acid reflux, and increased nausea

You are primarily managing blood sugar with weight loss as a secondary goal

Clinical data shows tirzepatide produces 21-23% body weight reduction over 68 weeks compared to semaglutide's 17-18%, particularly in patients whose genetic profile shows lower GLP1R sensitivity or higher GIP-pathway activation